Effects of Effera Human Lactoferrin at One Dose Compared to Placebo on Gut Permeability

Part of paid clinical trials in Addison, Illinois.

Sponsor
Helaina Inc.
Study ID
NCT07035964
Status
Recruiting
Apply to this trial

Conditions

  • Gut Health
  • Gut Permeability

Eligibility Criteria

Sex
ALL
Age
18 Years - 40 Years
Healthy Volunteers
Accepted

Interventions

  • human lactoferrin — DIETARY_SUPPLEMENT
    effera human lactoferrin
  • Placebo — DIETARY_SUPPLEMENT
    Placebo Control

Study Details

The purpose of this study is to evaluate the impact of 28-day supplementation with effera human lactoferrin, compared to a placebo control product on indicators of gut barrier health in males and females

Key Dates

Start date
Jun 4, 2025
Status verified
Jun 2025
Primary completion
Aug 30, 2025
Completion
Aug 30, 2025

Study Design

Enrollment
46 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER

Arms

  • Experimental: Dietary supplement: effera human lactoferrin
    Dietary supplement: effera human lactoferrin
  • Placebo Comparator: Dietary Supplement: Placebo Control
    Dietary Supplement: Placebo Control

Primary Outcome Measure

lactulose to mannitol ratio [ Time Frame: 0, 4 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Biofortis IncAddisonIllinois60101
Dr Antoo, MD
[email protected]
630-617-200

Find similar trials in Addison, IL

By research site
Biofortis Inc· Addison, IL

Related Studies